China Gerui AMG (CHOP) Misses Q4 EPS by 9c; Guides Below For FY12
Tweet Send to a FriendGet Alerts CHOP Hot Sheet
Trade CHOP Now!
China Gerui AMG (NASDAQ: CHOP) reported Q4 EPS of $0.31, $0.09 worse than the analyst estimate of $0.40. Revenue for the quarter came in at $91.9 million versus the consensus estimate of $105.84 million.
China Gerui AMG sees FY2012 EPS of $1.32-$1.37, versus the consensus of $1.56. China Gerui AMG sees FY2012 revenue of $395-$410 million, versus the consensus of $450 million.
In the fourth quarter of fiscal year 2011, the Company experienced a contraction in both its average selling prices and sales volume as compared to the third quarter of fiscal year 2011, primarily due to two factors.
For earnings history and earnings-related data on China Gerui AMG (CHOP) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
China Gerui AMG sees FY2012 EPS of $1.32-$1.37, versus the consensus of $1.56. China Gerui AMG sees FY2012 revenue of $395-$410 million, versus the consensus of $450 million.
In the fourth quarter of fiscal year 2011, the Company experienced a contraction in both its average selling prices and sales volume as compared to the third quarter of fiscal year 2011, primarily due to two factors.
For earnings history and earnings-related data on China Gerui AMG (CHOP) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- American Eagle Outfitters, Inc. (AEO) Tops Q1 EPS by 1c; Issues Weak EPS Outlook
- Medtronic, Inc. (MDT) Tops Q4 EPS by 7c; Guides FY14
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

